Published on 7/22/2009 in the Prospect News PIPE Daily.
New Issue: Response Genetics sells $3.98 million of its common stock in placement
By Devika Patel
Knoxville, Tenn., July 22 - Response Genetics, Inc. announced that it took in $3.98 million in a private placement of stock.
The company sold 3,057,907 common shares at $1.30 apiece to funds managed by Lansdowne Partners Ltd. Partnership.
Response Genetics is a Los Angeles company, which researches and develops clinical diagnostic tests for cancer.
| Issuer: | Response Genetics, Inc.
|
| Issue: | Common stock
|
| Amount: | $3,975,279.10
|
| Shares: | 3,057,907
|
| Price: | $1.30
|
| Warrants: | No
|
| Investor: | Lansdowne Partners Ltd. Partnership
|
| Settlement date: | July 22
|
| Stock symbol: | Nasdaq: RGDX
|
| Stock price: | $1.20 at close July 22
|
| Market capitalization: | $14.7 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
